Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pyroptosis correlates with tumor immunity and prognosis. | Commun Biol | 2022 | 36068291 | PubTator, text mining | PubMed |
| The overexpression of GPX8 is correlated with poor prognosis in GBM patients. | Front Genet | 2022 | 36061208 | PubTator, text mining | PubMed |
| Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia. | Front Genet | 2022 | 36061194 | PubTator, text mining | PubMed |
| Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer. | Front Genet | 2022 | 36061184 | PubTator, text mining | PubMed |
| Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma. | Front Oncol | 2022 | 36059641 | PubTator, text mining | PubMed |
| CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. | Front Immunol | 2022 | 36052076 | PubTator, text mining | PubMed |
| Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth. | Redox Biol | 2022 | 36044789 | PubTator, text mining | PubMed |
| Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis. | Cancer Control | 2022 | 36036380 | PubTator, text mining | PubMed |
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma. | Front Pharmacol | 2022 | 36016575 | PubTator, text mining | PubMed |
| Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36011030 | PubTator, text mining | PubMed |
| Recent Advances and Challenges in Cancer Immunotherapy. | Cancers (Basel) | 2022 | 36010965 | PubTator, text mining | PubMed |
| Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study. | Cancers (Basel) | 2022 | 36010914 | PubTator, text mining | PubMed |
| Tumor-Promoting ATAD2 and Its Preclinical Challenges. | Biomolecules | 2022 | 36008934 | PubTator, text mining | PubMed |
| Perinatal derivatives: How to best characterize their multimodal functions in vitro. Part C: Inflammation, angiogenesis, and wound healing. | Front Bioeng Biotechnol | 2022 | 35992360 | PubTator, text mining | PubMed |
| X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer. | Front Genet | 2022 | 35991556 | PubTator, text mining | PubMed |
| Immune cellular components and signaling pathways in the tumor microenvironment. | Semin Cancer Biol | 2022 | 35985559 | PubTator, text mining | PubMed |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts. | J Hematol Oncol | 2022 | 35978433 | PubTator, text mining | PubMed |
| Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer. | BMC Cancer | 2022 | 35974300 | PubTator, text mining | PubMed |
| Macrophages as tools and targets in cancer therapy. | Nat Rev Drug Discov | 2022 | 35974096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=37